Skip to main content

Benzo[e][1,4]diazepin-7-ium compound

ADVERTISEMENT
Identification
Molecular formula
C15H17ClN3O
CAS number
123456-78-9
IUPAC name
4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium;chloride
State
State

At room temperature, this compound is typically a solid due to its ionic nature, formed by the combination of a morpholinium cation and a chloride anion.

Melting point (Celsius)
223.00
Melting point (Kelvin)
496.00
Boiling point (Celsius)
350.00
Boiling point (Kelvin)
623.00
General information
Molecular weight
317.78g/mol
Molar mass
317.7800g/mol
Density
1.2000g/cm3
Appearence

The compound 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium chloride typically appears as a white to off-white crystalline powder. It may also be known as a solid based on its ionic state at room temperature. It is soluble in water due to its ionic nature, forming clear solutions.

Comment on solubility

Solubility of 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium;chloride

The solubility of the compound 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium;chloride can be understood through various factors that influence its behavior in different solvents. Here are some key points to consider:

  • Polar solvents: Due to the presence of ionic and polar functional groups within the structure, this compound is likely to exhibit a higher solubility in polar solvents such as water and alcohols.
  • Non-polar solvents: Conversely, the solubility in non-polar solvents may be limited. The complex aromatic system might hinder effective interaction with non-polar molecules.
  • Temperature effects: An increase in temperature usually promotes solubility, hence warmer conditions could enhance the overall solubility of this compound.
  • pH influence: The solubility can also vary with pH; in more acidic or basic environments, the compound might ionize or deprotonate, altering solubility dynamics.

As noted, understanding the solubility characteristics of this compound is crucial for its applications and functionality in various chemical environments. Each factor plays a significant role, emphasizing the importance of considering solvent interactions in the overall solubility behavior.

Interesting facts

Interesting Facts about 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium;chloride

This fascinating compound, commonly referred to as a member of the benzodiazepine family, carries both intriguing structural features and potential therapeutic applications. Here are some noteworthy aspects:

  • Benzodiazepine Framework: The compound features a unique fusion of the benzodiazepine structure, known for its role in anxiety and sedative medications. This specific framework contributes to its biological activity.

  • Potential Uses: Compounds like this one are often researched for their neuropharmacological properties. Studies suggest they could be explored for therapeutic effects in treating conditions such as anxiety disorders and seizures.

  • Morpholin-4-ium Influence: The presence of the morpholin-4-ium ion adds a layer of complexity, enhancing solubility and bioavailability, which is crucial for drug development.

  • Research Interests: This compound’s rich structural characteristics make it a subject of interest for synthetic chemists aiming to develop new drugs. Researchers focus on how slight modifications can lead to significant changes in activity and selectivity.

  • Implications in Medicinal Chemistry: The study of compounds like this is vital in medicinal chemistry, as understanding the interaction between their structures and biological targets can lead to better therapeutic agents.

In summary, 4-(7H-benzo[d][1,3]benzodiazepin-6-yl)morpholin-4-ium;chloride represents a fascinating intersection of structure and function, signaling promise in further research within the pharmacological landscape. With ongoing studies, the potential applications of this compound continue to expand, making it an exciting topic for both chemists and pharmacologists alike.

Synonyms
6-Morpholino-5H-dibenzo(d,f)(1,3)diazepine hydrochloride
5H-DIBENZO(d,f)(1,3)DIAZEPINE, 6-MORPHOLINO-, MONOHYDROCHLORIDE
2849-07-2